Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders

<!--[if gte mso 9]><xml> Normal 0 false false false MicrosoftInternetExplorer4 </xml><![endif]--><!--[if gte mso 9]><xml> </xml><![endif]--> <!--[if gte mso 10]> <styl...

Full description

Bibliographic Details
Main Author: Mansour Homayouni
Format: Article
Language:English
Published: Knowledge E 2009-04-01
Series:Journal of Ophthalmic & Vision Research
Online Access:http://www.jovr.ir/index.php/jovr/article/view/107
_version_ 1811332973659684864
author Mansour Homayouni
author_facet Mansour Homayouni
author_sort Mansour Homayouni
collection DOAJ
description <!--[if gte mso 9]><xml> Normal 0 false false false MicrosoftInternetExplorer4 </xml><![endif]--><!--[if gte mso 9]><xml> </xml><![endif]--> <!--[if gte mso 10]> <style>
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:"Table Normal";
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-parent:"";
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
 mso-para-margin:0cm;
 mso-para-margin-bottom:.0001pt;
 mso-pagination:widow-orphan;
 font-size:10.0pt;
 font-family:"Times New Roman";
 mso-ansi-language:#0400;
 mso-fareast-language:#0400;
 mso-bidi-language:#0400;}
 </style> <![endif]--> <p>The introduction of pharmacotherapy has been one of the most important advances in the management of retinal disorders. Age-related macular degeneration (AMD) was once considered as an irrepressible disease leading to permanent macular damage, however anti-vascular endothelial growth factor (anti-VEGF) agents are now believed to halt the progression of the condition and improve vision in a considerable proportion of patients. Anti-VEGF agents are among the most commonly used drugs in ophthalmology but questions and uncertainties still surround their indications, efficacy and complications. This paper reviews the role of VEGF under physiologic and pathologic conditions in the eye and available anti-VEGF agents in current ophthalmic practice.</p>
first_indexed 2024-04-13T16:45:03Z
format Article
id doaj.art-e6372676339f49bc935265bb24d23406
institution Directory Open Access Journal
issn 2008-2010
2008-322X
language English
last_indexed 2024-04-13T16:45:03Z
publishDate 2009-04-01
publisher Knowledge E
record_format Article
series Journal of Ophthalmic & Vision Research
spelling doaj.art-e6372676339f49bc935265bb24d234062022-12-22T02:39:06ZengKnowledge EJournal of Ophthalmic & Vision Research2008-20102008-322X2009-04-0142105114Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular DisordersMansour Homayouni<!--[if gte mso 9]><xml> Normal 0 false false false MicrosoftInternetExplorer4 </xml><![endif]--><!--[if gte mso 9]><xml> </xml><![endif]--> <!--[if gte mso 10]> <style>
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:"Table Normal";
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-parent:"";
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
 mso-para-margin:0cm;
 mso-para-margin-bottom:.0001pt;
 mso-pagination:widow-orphan;
 font-size:10.0pt;
 font-family:"Times New Roman";
 mso-ansi-language:#0400;
 mso-fareast-language:#0400;
 mso-bidi-language:#0400;}
 </style> <![endif]--> <p>The introduction of pharmacotherapy has been one of the most important advances in the management of retinal disorders. Age-related macular degeneration (AMD) was once considered as an irrepressible disease leading to permanent macular damage, however anti-vascular endothelial growth factor (anti-VEGF) agents are now believed to halt the progression of the condition and improve vision in a considerable proportion of patients. Anti-VEGF agents are among the most commonly used drugs in ophthalmology but questions and uncertainties still surround their indications, efficacy and complications. This paper reviews the role of VEGF under physiologic and pathologic conditions in the eye and available anti-VEGF agents in current ophthalmic practice.</p>http://www.jovr.ir/index.php/jovr/article/view/107
spellingShingle Mansour Homayouni
Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders
Journal of Ophthalmic & Vision Research
title Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders
title_full Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders
title_fullStr Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders
title_full_unstemmed Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders
title_short Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders
title_sort vascular endothelial growth factors and their inhibitors in ocular neovascular disorders
url http://www.jovr.ir/index.php/jovr/article/view/107
work_keys_str_mv AT mansourhomayouni vascularendothelialgrowthfactorsandtheirinhibitorsinocularneovasculardisorders